Institutions / Enavate Sciences GP, LLC

Enavate Sciences GP, LLC

CIK 1953107 · Institution · as of Dec 31, 2025
Portfolio value
$506.78M
Positions
7
As of
Dec 31, 2025

Top holdings

Dec 31, 2025
CompanyClassValueShares% of portfolio
Zenas BioPharma, Inc.ZBIOCommon Stock$142.30M3,919,15928.1%
Immunome Inc.—$102.43M4,768,58320.2%
Sionna Therapeutics, Inc.—$101.95M2,478,03020.1%
Upstream Bio, Inc.UPBCommon Stock$66.78M2,459,70313.2%
Compass Therapeutics, Inc.—$41.82M7,788,1508.3%
BridgeBio Oncology Therapeutics, Inc.BBOTCommon Stock$32.89M2,626,9466.5%
Camp4 Therapeutics Corp—$18.61M3,035,8253.7%

Activity

Dec 31, 2025
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.
No quarter-over-quarter changes yet — position changes appear once we've ingested two consecutive 13F filings for this manager. We currently hold 1 quarter of holdings.